Every night, a slew of TV commercials hammer home the benefits of drugs that treat autoimmune diseases such as psoriasis and rheumatoid arthritis — and tack on a reminder about the risks they carry.
More than most, Tom Leith knows the possible perils.
Over the last 20 years, he has been on three of the drugs for his rheumatoid arthritis: Enbrel, Orencia and Rituxan.
